Sheng-Jie Jin
Clinical Medical College of Yangzhou University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sheng-Jie Jin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:34 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT04645550 · Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT)Northern Jiangsu People's Hospital · completed · Cirrhosis, Splenectomy; Status, Venous Thrombosis · principal investigator
- Ph4NCT02247414 · Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal DisconnectionYangzhou University · completed · Cirrhosis, Hypertension, Status;Splenectomy · principal investigator
- Ph4NCT02238444 · Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic SplenectomyYangzhou University · unknown · Cirrhosis, Hypertension, Venous Thrombosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:34 UTC. The ranking covers the 200 most relevant of 226 PubMed records, and a shared surname and initials can bring in a namesake. All 226 on PubMed
- Vitamin E and donepezil for the treatment of mild cognitive impairment.N Engl J Med · 20051,337 citationsRCR 36.4
- 756 citationsRCR 17.7
- 731 citationsRCR 20.1
- 409 citationsRCR 12.0
- 338 citationsRCR 38.1
- 262 citationsRCR 12.3
- Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial.Cancer Discov · 2021192 citationsRCR 9.2
- Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01).J Clin Oncol · 2023173 citationsRCR 10.8
- 164 citationsRCR 5.9
- Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.CMAJ · 2012148 citationsRCR 5.9